Thrombosis of a Left Atrial Appendage Occluder After Treatment With Thrombopoietin Receptor Agonists

JACC Cardiovasc Interv. 2018 Jan 22;11(2):e15-e16. doi: 10.1016/j.jcin.2017.11.008. Epub 2017 Dec 27.

Authors

Hector Cubero-Gallego¹, Rafael Romaguera², Luis Teruel², Josep Gomez-Lara², Javier Berdejo², Joan A Gomez-Hospital², Angel Cequier²

Affiliations

¹ Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain. Electronic address: hektorkubero@hotmail.com.
² Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain.

PMID: 29289629
DOI: 10.1016/j.jcin.2017.11.008

No abstract available

Keywords: left atrial appendage occluder; thrombopoietin receptor agonists; thrombosis.

Publication types

Case Reports
Video-Audio Media

MeSH terms

Aged
Atrial Appendage* / diagnostic imaging
Atrial Appendage* / surgery
Atrial Fibrillation / complications
Atrial Fibrillation / diagnostic imaging
Atrial Fibrillation / surgery
Atrial Fibrillation / therapy*
Benzoates / adverse effects*
Cardiac Catheterization / adverse effects*
Cardiac Catheterization / instrumentation
Device Removal
Echocardiography, Three-Dimensional
Hematologic Agents / adverse effects*
Humans
Hydrazines / adverse effects*
Male
Purpura, Thrombocytopenic, Idiopathic / blood
Purpura, Thrombocytopenic, Idiopathic / complications
Purpura, Thrombocytopenic, Idiopathic / drug therapy*
Pyrazoles / adverse effects*
Receptors, Thrombopoietin / agonists*
Risk Factors
Thrombectomy
Thrombosis / diagnostic imaging
Thrombosis / etiology*
Thrombosis / surgery
Treatment Outcome

Substances

Benzoates
Hematologic Agents
Hydrazines
Pyrazoles
Receptors, Thrombopoietin
MPL protein, human
eltrombopag